ArticleFrontiers in pediatrics2026
A novel age-norm-capped baseline serum creatinine approach for acute kidney injury diagnosis in critically Ill children: a retrospective cohort study.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: A reliable baseline serum creatinine (SCr) for pediatric acute kidney injury (AKI) diagnosis is often missing, and simply using admission SCr may underestimate AKI. We aimed to evaluate a novel approach for defining baseline SCr by comparing its implications for AKI classification and prognosis with those of admission SCr. Methods: This retrospective study utilized data from the Paediatric Intensive Care (PIC) database. We compared two distinct baseline SCr definitions: 1) the "Admission SCr" and 2) a novel "Norms-Capped SCr", defined as the admission SCr if it was less than or equal to the age-specific normal maximum (NormsMax), or the NormsMax value if the admission SCr exceeded it. Both baseline definitions were then used to classify AKI according to three different diagnostic criteria. We subsequently compared the resulting AKI incidence, stage distribution, and prognostic performance for clinical outcomes across these different baseline-criterion combinations. Results: A total of 3,021 critically ill children were included. Norms-Capped SCr identified more AKI than admission SCr across KDIGO (41.7% vs. 27.4%), pROCK (38.7% vs. 27.5%), and pRIFLE (55.1% vs. 32.6%). It also showed more consistent associations with in-hospital mortality, although pRIFLE Stage 3 was not significant. Apparent AUCs ranged from 0.797 to 0.817 for Norms-Capped SCr models and from 0.783 to 0.785 for admission SCr models; the corresponding optimism-corrected AUCs were 0.784-0.804 and 0.767-0.770, respectively. Calibration was comparable, while prediction error was slightly lower with Norms-Capped SCr. Conclusion: The Norms-Capped SCr approach showed modestly better overall performance than admission SCr for defining baseline SCr in critically ill children without known pre-admission values, particularly when combined with the pROCK criteria.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.